Highlights
The global Gene Subcloning Service market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Gene Subcloning Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gene Subcloning Service is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Gene Subcloning Service in Academic and Research Institutions is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Gene Subcloning Service include Thermo Fisher Scientific, Eurofins Scientific, Merck KGaA, Genscript Biotech Corp, Synbio Technologies, Bio Basic, Bioneer Corporation, Applied Biological Materials and Takara Bio, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gene Subcloning Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Subcloning Service.
The Gene Subcloning Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gene Subcloning Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Subcloning Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Eurofins Scientific
Merck KGaA
Genscript Biotech Corp
Synbio Technologies
Bio Basic
Bioneer Corporation
Applied Biological Materials
Takara Bio
Canvax Biotech
Codex DNA
Azenta US
Macrogen
InvivoGen
BioCat GmbH
BEX Co., Ltd
Lonza Group
Segment by Type
Stranded Gene
Complex Gene
Others
Segment by Application
Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Subcloning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Subcloning Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Stranded Gene
1.2.3 Complex Gene
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gene Subcloning Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institutions
1.3.3 Clinical Laboratories
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Subcloning Service Market Perspective (2018-2029)
2.2 Gene Subcloning Service Growth Trends by Region
2.2.1 Global Gene Subcloning Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gene Subcloning Service Historic Market Size by Region (2018-2023)
2.2.3 Gene Subcloning Service Forecasted Market Size by Region (2024-2029)
2.3 Gene Subcloning Service Market Dynamics
2.3.1 Gene Subcloning Service Industry Trends
2.3.2 Gene Subcloning Service Market Drivers
2.3.3 Gene Subcloning Service Market Challenges
2.3.4 Gene Subcloning Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Subcloning Service Players by Revenue
3.1.1 Global Top Gene Subcloning Service Players by Revenue (2018-2023)
3.1.2 Global Gene Subcloning Service Revenue Market Share by Players (2018-2023)
3.2 Global Gene Subcloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Subcloning Service Revenue
3.4 Global Gene Subcloning Service Market Concentration Ratio
3.4.1 Global Gene Subcloning Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Subcloning Service Revenue in 2022
3.5 Gene Subcloning Service Key Players Head office and Area Served
3.6 Key Players Gene Subcloning Service Product Solution and Service
3.7 Date of Enter into Gene Subcloning Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Subcloning Service Breakdown Data by Type
4.1 Global Gene Subcloning Service Historic Market Size by Type (2018-2023)
4.2 Global Gene Subcloning Service Forecasted Market Size by Type (2024-2029)
5 Gene Subcloning Service Breakdown Data by Application
5.1 Global Gene Subcloning Service Historic Market Size by Application (2018-2023)
5.2 Global Gene Subcloning Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Subcloning Service Market Size (2018-2029)
6.2 North America Gene Subcloning Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gene Subcloning Service Market Size by Country (2018-2023)
6.4 North America Gene Subcloning Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Subcloning Service Market Size (2018-2029)
7.2 Europe Gene Subcloning Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gene Subcloning Service Market Size by Country (2018-2023)
7.4 Europe Gene Subcloning Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Subcloning Service Market Size (2018-2029)
8.2 Asia-Pacific Gene Subcloning Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gene Subcloning Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Gene Subcloning Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Subcloning Service Market Size (2018-2029)
9.2 Latin America Gene Subcloning Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gene Subcloning Service Market Size by Country (2018-2023)
9.4 Latin America Gene Subcloning Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Subcloning Service Market Size (2018-2029)
10.2 Middle East & Africa Gene Subcloning Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gene Subcloning Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Gene Subcloning Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Gene Subcloning Service Introduction
11.1.4 Thermo Fisher Scientific Revenue in Gene Subcloning Service Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Gene Subcloning Service Introduction
11.2.4 Eurofins Scientific Revenue in Gene Subcloning Service Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Gene Subcloning Service Introduction
11.3.4 Merck KGaA Revenue in Gene Subcloning Service Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Genscript Biotech Corp
11.4.1 Genscript Biotech Corp Company Detail
11.4.2 Genscript Biotech Corp Business Overview
11.4.3 Genscript Biotech Corp Gene Subcloning Service Introduction
11.4.4 Genscript Biotech Corp Revenue in Gene Subcloning Service Business (2018-2023)
11.4.5 Genscript Biotech Corp Recent Development
11.5 Synbio Technologies
11.5.1 Synbio Technologies Company Detail
11.5.2 Synbio Technologies Business Overview
11.5.3 Synbio Technologies Gene Subcloning Service Introduction
11.5.4 Synbio Technologies Revenue in Gene Subcloning Service Business (2018-2023)
11.5.5 Synbio Technologies Recent Development
11.6 Bio Basic
11.6.1 Bio Basic Company Detail
11.6.2 Bio Basic Business Overview
11.6.3 Bio Basic Gene Subcloning Service Introduction
11.6.4 Bio Basic Revenue in Gene Subcloning Service Business (2018-2023)
11.6.5 Bio Basic Recent Development
11.7 Bioneer Corporation
11.7.1 Bioneer Corporation Company Detail
11.7.2 Bioneer Corporation Business Overview
11.7.3 Bioneer Corporation Gene Subcloning Service Introduction
11.7.4 Bioneer Corporation Revenue in Gene Subcloning Service Business (2018-2023)
11.7.5 Bioneer Corporation Recent Development
11.8 Applied Biological Materials
11.8.1 Applied Biological Materials Company Detail
11.8.2 Applied Biological Materials Business Overview
11.8.3 Applied Biological Materials Gene Subcloning Service Introduction
11.8.4 Applied Biological Materials Revenue in Gene Subcloning Service Business (2018-2023)
11.8.5 Applied Biological Materials Recent Development
11.9 Takara Bio
11.9.1 Takara Bio Company Detail
11.9.2 Takara Bio Business Overview
11.9.3 Takara Bio Gene Subcloning Service Introduction
11.9.4 Takara Bio Revenue in Gene Subcloning Service Business (2018-2023)
11.9.5 Takara Bio Recent Development
11.10 Canvax Biotech
11.10.1 Canvax Biotech Company Detail
11.10.2 Canvax Biotech Business Overview
11.10.3 Canvax Biotech Gene Subcloning Service Introduction
11.10.4 Canvax Biotech Revenue in Gene Subcloning Service Business (2018-2023)
11.10.5 Canvax Biotech Recent Development
11.11 Codex DNA
11.11.1 Codex DNA Company Detail
11.11.2 Codex DNA Business Overview
11.11.3 Codex DNA Gene Subcloning Service Introduction
11.11.4 Codex DNA Revenue in Gene Subcloning Service Business (2018-2023)
11.11.5 Codex DNA Recent Development
11.12 Azenta US
11.12.1 Azenta US Company Detail
11.12.2 Azenta US Business Overview
11.12.3 Azenta US Gene Subcloning Service Introduction
11.12.4 Azenta US Revenue in Gene Subcloning Service Business (2018-2023)
11.12.5 Azenta US Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Detail
11.13.2 Macrogen Business Overview
11.13.3 Macrogen Gene Subcloning Service Introduction
11.13.4 Macrogen Revenue in Gene Subcloning Service Business (2018-2023)
11.13.5 Macrogen Recent Development
11.14 InvivoGen
11.14.1 InvivoGen Company Detail
11.14.2 InvivoGen Business Overview
11.14.3 InvivoGen Gene Subcloning Service Introduction
11.14.4 InvivoGen Revenue in Gene Subcloning Service Business (2018-2023)
11.14.5 InvivoGen Recent Development
11.15 BioCat GmbH
11.15.1 BioCat GmbH Company Detail
11.15.2 BioCat GmbH Business Overview
11.15.3 BioCat GmbH Gene Subcloning Service Introduction
11.15.4 BioCat GmbH Revenue in Gene Subcloning Service Business (2018-2023)
11.15.5 BioCat GmbH Recent Development
11.16 BEX Co., Ltd
11.16.1 BEX Co., Ltd Company Detail
11.16.2 BEX Co., Ltd Business Overview
11.16.3 BEX Co., Ltd Gene Subcloning Service Introduction
11.16.4 BEX Co., Ltd Revenue in Gene Subcloning Service Business (2018-2023)
11.16.5 BEX Co., Ltd Recent Development
11.17 Lonza Group
11.17.1 Lonza Group Company Detail
11.17.2 Lonza Group Business Overview
11.17.3 Lonza Group Gene Subcloning Service Introduction
11.17.4 Lonza Group Revenue in Gene Subcloning Service Business (2018-2023)
11.17.5 Lonza Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Eurofins Scientific
Merck KGaA
Genscript Biotech Corp
Synbio Technologies
Bio Basic
Bioneer Corporation
Applied Biological Materials
Takara Bio
Canvax Biotech
Codex DNA
Azenta US
Macrogen
InvivoGen
BioCat GmbH
BEX Co., Ltd
Lonza Group
*If Applicable.